English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Structural and mechanistic basis for translation inhibition by macrolide and ketolide antibiotics

MPS-Authors
/persons/resource/persons14865

Bock,  L. V.
Department of Theoretical and Computational Biophysics, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15155

Grubmüller,  H.
Department of Theoretical and Computational Biophysics, MPI for biophysical chemistry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (public)

3347486.pdf
(Publisher version), 4MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Beckert, B., Leroy, E. C., Sothiselvam, S., Bock, L. V., Svetlov, M. S., Graf, M., et al. (2021). Structural and mechanistic basis for translation inhibition by macrolide and ketolide antibiotics. Nature Communications, 12: 4466. doi:10.1038/s41467-021-24674-9.


Cite as: http://hdl.handle.net/21.11116/0000-0009-63F9-F
Abstract
Macrolides and ketolides comprise a family of clinically important antibiotics that inhibit protein synthesis by binding within the exit tunnel of the bacterial ribosome. While these antibiotics are known to interrupt translation at specific sequence motifs, with ketolides predominantly stalling at Arg/Lys-X-Arg/Lys motifs and macrolides displaying a broader specificity, a structural basis for their context-specific action has been lacking. Here, we present structures of ribosomes arrested during the synthesis of an Arg-Leu-Arg sequence by the macrolide erythromycin (ERY) and the ketolide telithromycin (TEL). Together with deep mutagenesis and molecular dynamics simulations, the structures reveal how ERY and TEL interplay with the Arg-Leu-Arg motif to induce translational arrest and illuminate the basis for the less stringent sequence-specific action of ERY over TEL. Because programmed stalling at the Arg/Lys-X-Arg/Lys motifs is used to activate expression of antibiotic resistance genes, our study also provides important insights for future development of improved macrolide antibiotics.